Clearside Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
32
Employees32
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
32
Employees32

CLSD Key Statistics

Market cap
31.77M
Market cap31.77M
Price-Earnings ratio
-1.48
Price-Earnings ratio-1.48
Dividend yield
Dividend yield
Average volume
509.68K
Average volume509.68K
High today
$0.6399
High today$0.6399
Low today
$0.3902
Low today$0.3902
Open price
$0.58
Open price$0.58
Volume
3.65M
Volume3.65M
52 Week high
$1.65
52 Week high$1.65
52 Week low
$0.3201
52 Week low$0.3201

CLSD News

TipRanks 13h
Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgraded Clearside Biomedical (CLSD) to Neutral from Buy without a price target after the company said it is exploring strategic alternatives....

TipRanks 1d
Clearside Biomedical downgraded to Hold from Buy at Needham

Needham downgraded Clearside Biomedical (CLSD) to Hold from Buy with a $3 price target Published first on TheFly – the ultimate source for real-time, market-mo...

Analyst ratings

86%

of 7 ratings
Buy
14.3%
Hold
85.7%
Sell
0%

People also own

Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.